696 related articles for article (PubMed ID: 23876340)
1. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effect of a newly developed AMP-activated protein kinase activator YLF-466D.
Liu Y; Park JM; Oh SJ; Chang KH; Lee MY
Eur J Pharmacol; 2015 Aug; 760():81-7. PubMed ID: 25913239
[TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
[TBL] [Abstract][Full Text] [Related]
4. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle.
Lira VA; Soltow QA; Long JH; Betters JL; Sellman JE; Criswell DS
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1062-8. PubMed ID: 17666490
[TBL] [Abstract][Full Text] [Related]
6. Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes.
McConell GK; Ng GP; Phillips M; Ruan Z; Macaulay SL; Wadley GD
J Appl Physiol (1985); 2010 Mar; 108(3):589-95. PubMed ID: 20044477
[TBL] [Abstract][Full Text] [Related]
7. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
9. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
10. Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.
Li C; Reif MM; Craige SM; Kant S; Keaney JF
Nitric Oxide; 2016 May; 55-56():45-53. PubMed ID: 26989010
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation.
Davis B; Rahman A; Arner A
Eur J Pharmacol; 2012 Nov; 695(1-3):88-95. PubMed ID: 22921370
[TBL] [Abstract][Full Text] [Related]
12. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
[TBL] [Abstract][Full Text] [Related]
13. κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation.
Zhang S; Zhou Y; Zhao L; Tian X; Jia M; Gu X; Feng N; An R; Yang L; Zheng G; Li J; Guo H; Fan R; Pei J
Eur J Pharmacol; 2018 Aug; 833():100-108. PubMed ID: 29856969
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats.
Ford RJ; Teschke SR; Reid EB; Durham KK; Kroetsch JT; Rush JW
J Hypertens; 2012 Apr; 30(4):725-33. PubMed ID: 22306847
[TBL] [Abstract][Full Text] [Related]
15. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
17. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
Oki K; Arias EB; Kanzaki M; Cartee GD
Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
[TBL] [Abstract][Full Text] [Related]
18. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M
Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081
[TBL] [Abstract][Full Text] [Related]
19. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
20. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
Shearer J; Fueger PT; Rottman JN; Bracy DP; Martin PH; Wasserman DH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E871-7. PubMed ID: 15265760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
